Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Oxford Biotherapeutics Ltd

Clinical trials sponsored by Oxford Biotherapeutics Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New smart drug targets cancer cells in advanced tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New smart drug targets cancer cells in advanced tumors

Disease control Recruiting now

This early-stage trial tests OBT076, a drug that combines an antibody with a chemotherapy agent to target and kill cancer cells that have a specific protein called CD205. The study includes up to 200 adults with advanced solid tumors that have not responded to standard treatments…

Phase 1 • Sponsor: Oxford BioTherapeutics Ltd • Aim: Disease control

Last updated Jun 26, 2026 17:29 UTC